INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Atika Capital Management LLC's Holding History (CIK: 0001599731)

Note: Option positions (PUT/CALL) are excluded.

Q2 2014
Shares 2,200 Value ($000) $521 Avg Close — Range —
Q1 2014
Shares 13,580 Value ($000) $4,479 Avg Close — Range —
Q4 2013
Shares 19,000 Value ($000) $1,297 Avg Close — Range —